NCT00623987View on ClinicalTrials.gov

Absence of Residual Vein Thrombosis Permits to Withdrawn Oral Anticoagulants

PHASE4CompletedINTERVENTIONAL
Enrollment

500

Participants

Timeline

Start Date

June 30, 1999

Primary Completion Date

June 30, 2006

Study Completion Date

January 31, 2008

Conditions
Deep Vein Thrombosis
Interventions
DRUG

warfarin accordingly INR value

warfarin accordingly to INR value between 2.0-3.0

Trial Locations (1)

90127

Sergio Siragusa, Palermo

All Listed Sponsors
lead

Azienda Ospedaliera Universitaria Policlinico

OTHER

NCT00623987 - Absence of Residual Vein Thrombosis Permits to Withdrawn Oral Anticoagulants | Biotech Hunter | Biotech Hunter